ESR1 and neoplasm: The expression of ZFX variant 5 significantly elevated in ER-positive (p < 0.05), HER2-positive (p < 0.05; Table 2), and P53-negative (p < 0.05) tumor tissues in comparison to ER-negative, HER2-negative, and P53-positive, respectively.